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Abstract
The combination of highly efficient polymerizations with modular “click” coupling reactions has
enabled the synthesis of wide variety of novel nanoscopic structures. Here we demonstrate the
facile synthesis of a new class of clickable, branched nanostructures, polyethylene glycol (PEG)-
branch-azide bivalent-brush polymers, facilitated by “graft-through” ring-opening metathesis
polymerization (ROMP) of a branched norbornene-PEG-chloride macromonomer followed by
halide-azide exchange. The resulting bivalent-brush polymers possess azide groups at the core
near a polynorbornene backbone with PEG chains extended into solution; the structure resembles
a unimolecular micelle. We demonstrate copper-catalyzed azide-alkyne cycloaddition (CuAAC)
“click-to” coupling of a photocleavable doxorubicin (DOX)-alkyne derivative to the azide core.
The CuAAC coupling was quantitative across a wide range of nanoscopic sizes (~6 – ~50 nm);
UV photolysis of the resulting DOX-loaded materials yielded free DOX that was therapeutically
effective against human cancer cells.
Introduction
The explosion of nanoscience is fuelled by problems that require nanoscale solutions and by
the inherent challenges of nanoscale synthesis.1–3 In drug delivery, for example, plasma
clearance time of a polymer-drug conjugate is closely linked to its nanoscopic size; materials
smaller than 10 nm are excreted rapidly whereas larger materials often display significantly
longer retention times.3–9 Nanoscopic architecture also plays an important role in
determining in vivo retention time.10–12 Branched polymeric structures such as dendrimers,
star polymers, bottle-brush polymers, and hyperbranched polymers generally display longer
in vivo retention times compared to their linear polymer analogues.11,13 A wealth of
research attention has focused on synthetic approaches to branched, stimuli-responsive,
nanoscopic materials that possess orthogonal functionality for incorporation of therapeutic,
imaging, and targeting molecules.14–25
The most widely studied branched macromolecules for drug delivery are dendrimers; their
nanoscale, monodisperse, multi-valent structures provide functional handles for elaboration
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with bioactive groups of interest.26–28 One factor that limits widespread application of
dendrimers is synthetic difficulty. Though recent synthetic advances are impressive,16,29–32
it remains a challenge to prepare functionally diverse dendrimers of variable sizes. To
overcome this challenge, researchers have appended linear polymers to dendrimers33–36 or
prepared linear polymers with dendritic fragments attached to their sidechains. The latter
“dendronized linear polymers” have attracted attention as nanoscopic building blocks; their
cylindrical shapes can provide important advantages in nanoscale fabrication when
compared to spherical dendrimers.37–43 Similar nanoscale structures can be formed from
bottle-brush-polymers that carry long chains grafted at high density to linear polymer
backbones.44–63 Bottle-brush polymers are prepared by graft-to, graft-from, or graft-through
methodologies. The graft-to strategy requires an efficient coupling reaction to attach a
functional molecule to every monomer unit of a linear polymer; “click”64 reactions such as
the copper-catalyzed azide-alkyne cycloaddition65,66 (CuAAC) and thiol-ene coupling have
proven useful in this regard.43,46,67–70 Graft-from and graft-through methodologies require
highly efficient polymerization reactions capable of initiation and propagation in sterically-
demanding environments.48,51–53,71 Recent developments in efficient, controlled
polymerization coupled with new click reactions provide materials chemists with the tools to
generate novel functional nanoscopic materials.72–77
Ring-opening metathesis polymerization (ROMP) of strained alkene- (e.g. norbornene)-
terminated macromonomers (MM) initiated by ruthenium N-heterocyclic carbene complexes
(e.g. 1, Figure 1) has recently proven useful for graft-through synthesis of functional bottle-
brush polymers;50,78–83 fast initiation leads to low polydispersities (PDIs) while release of
ring strain provides the driving force for high conversion in these systems. Although catalyst
1 is incompatible with azides and alkynes, its functional group tolerance enables use of
monomers bearing azide and alkyne precursors that are easily converted to the requisite
click groups after polymerization. Binder and coworkers used ROMP combined with
CuAAC to append various small molecules to clickable linear polymers.84,85 We have used
ROMP in conjunction with CuAAC to generate cyclic polymers by end-to-end coupling.86
To our knowledge, there are no examples of water-soluble brush polymers prepared by
graft-through ROMP that are subsequently functionalized via click reactions. Such a
strategy combines the benefits of ROMP for graft-through brush polymer synthesis with the
modularity and efficiency of CuAAC for clicking-to; branched nanoscopic polymers with
easily addressable functional groups can be rapidly prepared over a wide range of sizes
simply by altering the ratio of catalyst to MM.
In this report we demonstrate the sequential combination of graft-through- and click-to
synthetic strategies to generate a clickable polyethylene glycol (PEG)-azide branched
polymer material: a bivalent-bottle-brush polymer (Figure 1). Graft-through ROMP of a
PEG-chloride macromonomer (Figure 1, Scheme 1, 6) gave bivalent-brush polymers of
varying nanoscopic sizes. These materials resemble 1st-generation dendronized polymers
with branch points located near the linear polymer backbone (Figure 1); attached on one side
of the branch point is a linear polymer and on the other side a small molecule (e.g. a drug).
This design incorporates a water-soluble PEG domain that extends into solvent and a
hydrophobic alkyl chloride near the core. We hypothesize that PEG attachment to one
branch of these bivalent-branch polymers will confer the biocompatibility widely observed
for PEGylated systems.6,87 Core-functionalized nanomaterials have been elaborated with
functional small molecules by click chemistry;88–92 in this work we convert the core alkyl
chlorides to azides by treatment with sodium azide. Then, we utilize CuAAC to couple
doxorubicin (DOX), to the core via a photo-cleavable nitrobenzyloxylcarbonyl (NBOC)
linker. The latter enables controlled release of free DOX in response to long-wavelength
(~365 nm) ultraviolet (UV) light; we demonstrate that released DOX is therapeutically
active against human cancer cells in culture.
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Results and Discussion
Synthesis of MM 6
Clickable bivalent PEG brush polymers can be generated from an MM containing a strained
norbornene derivative for ROMP, a PEG chain, and a functional group suitable for CuAAC
(Figure 1, Scheme 1). Since neither azides nor alkynes are compatible with catalyst 1, we
designed MM 6 to carry an alkyl chloride for facile conversion to an azide in a post-ROMP
modification step. We incorporated a 6-carbon spacer between the strained norbornene
moiety and the tertiary amide branch point to reduce steric hindrance between the growing
polymer chain end and the branched side-chains. This spacer may also facilitate subsequent
sidechain modification reactions, such as chloride to azide conversion and CuAAC. MM 6
was obtained in five steps from exo-N-(6-hydroxyhexyl)-5-norbornene-2,3-dicarboximide
(norb-C6OH, Scheme 1). The synthesis commenced with Swern oxidation of norb-C6OH
to give aldehyde 2. Reductive amination using 2 and 3-chloropropylamine hydrochloride
gave secondary amine 3, which was readily converted to acid 4 by treatment with succinic
anhydride. Reaction of 4 with N-hydroxysuccinimide (NHS) in the presence of N-(3-
dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (EDC) and catalytic 4-
(dimethylamino)pyridine (DMAP) gave NHS ester 5. We have prepared 5 on a multi-gram
scale and expect it to be useful for the preparation of a variety of multifunctional ROMP
monomers. In this work, commercially available 3 kDa PEG-NH2 was treated with a slight
excess of 5 to give MM 6. Excess 5 was used to ensure complete conversion of every PEG-
amine to amide 6; the only polymeric species in the final reaction mixture was 6 and it was
easily purified via repeated precipitation in diethyl ether. The 1H NMR, 13C NMR, and
MALDI spectra for MM 6 are provided in the supporting information.
Graft-through ROMP of 6 and halide-azide exchange to generate nN3 bivalent-brush
polymers
We pursued a one-pot synthetic strategy to rapidly generate a library of azide-functional
brush polymers (nN3) with variable number-average degrees of polymerization (DP) and
hydrodynamic radii. A strength of this approach is the ease of generating branched
functional materials of variable sizes rapidly and efficiently; each of the polymers described
here was prepared by adding an aliquot of catalyst 1 to a vial containing MM 6, allowing 60
min for ROMP to proceed, quenching the polymerization by addition of ethyl vinyl ether,
solvent exchange, and finally treatment with sodium azide (Scheme 2). The first several
steps were performed within a few hours whereas the final step, attaching azides to the
polymer sidechains, was left for 48 h to ensure high conversion.
The polymer characterization data in Table I demonstrate that ROMP of 6 is well-controlled
up to the highest DP tested; a small amount of catalyst deactivation and/or experimental
error may explain the larger-than-expected DP for the 400N3 samples. In general, polymers
with low polydispersities and molecular weights defined by the ratio of 6:1 were obtained.
The GPC traces for all samples (Figure 2A) show monomodal molecular weight
distributions and very high (>95%) MM conversions. All of the polymers were highly
soluble (>100 mg/mL) in water; aqueous DLS measurements (Table I, Figure 3B) confirm
that their nanoscopic dimensions increased with DP and were tunable over a broad range
(radii from 3 – 25 nm) of relevant sizes for drug delivery applications. Furthermore, DLS
(Figure 2B) shows that the particle size distributions are monomodal.
Graft-through ROMP ensures that every side chain unit possesses both a PEG chain and an
alkyl chloride; the weight percentage of chloride is independent of DP. It follows that if
every chloride is converted to an azide then the weight percentage of azide is also
independent of DP. One may expect sidechain modification reactions with bivalent-brush
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polymers to display DP-dependent conversion; perhaps increased DP would lead to lower
reaction yields because of increased steric hindrance. We have found that for both chloride-
azide exchange and CuAAC reactions there is no apparent difference in reaction yield across
the DP values studied here. Figure 3 shows the FTIR spectra for a subset of nN3 polymers
normalized to the PEG ether (C-O-C antisymmetric stretch) absorbance at ~1100 cm−1. The
intensities of the characteristic azide antisymmetric stretch (~2100 cm−1) are the same for
each DP, which suggests that the azide:PEG ratio is the same for each sample and that the
chloride-azide exchange reaction occurred with equal efficiency for each DP value.
Click chemistry using DOX-NBOC-alkyne 9
The ultimate application of these nN3 bivalent-brush polymers is defined by how they are
decorated with functional groups. For drug delivery applications one can imagine clicking a
drug-alkyne derivative attached via a cleavable linker group (Figure 1). The resulting
polymer would undergo controlled drug release in response to an external stimulus leaving
the brush polymer scaffold intact. In this work, we designed 9 for controlled release of DOX
in response to UV light after click coupling to the nN3 polymer scaffold (Scheme 3). Photo-
initiated release from macromolecules provides a means for site-specific, controlled drug
delivery and could potentially complement traditional phototherapeutic methods.93–103
Though placement of azide groups near the core of these bivalent-brush polymers should
allow PEG to extend into solution and increase the biocompatibility of these materials, a
buried location may make them difficult to functionalize with subsequent reactions.
Anticipating this challenge was one reason we chose two highly efficient reactions, halide-
azide exchange and CuAAC, as the modification reactions; as described above CuAAC has
proven useful for quantitative attachment of small molecules to the side chains of ROMP
polymers84,85 and we expected that it would provide the best opportunity for high-yield
coupling of sterically-demanding alkyne reagents to bivalent-branch polymers. There are a
variety of CuAAC conditions throughout the literature and the catalyst/ligand/solvent
system depends on the application;104–107 perhaps the most impressive applications of
CuAAC are in the field of bioconjugation where the requisite azide and alkyne functional
groups are present in very low concentration amongst a number of other reactive groups.108–
111
 The Finn laboratory recently reported optimized CuAAC conditions for bioconjugation
which utilize a new accelerating ligand THPTA (Scheme 4).112 Aqueous CuAAC was found
to proceed orders of magnitude faster with THPTA than in the absence of a ligand. Since
these nN3 bivalent-brush polymers are nanoscopic, narrowly-dispersed, water-soluble
materials with buried functional groups, we envisioned CuAAC reactions to them as similar
to bioconjugation reactions to proteins bearing multiple azide or alkyne groups. After initial
attempts without accelerating ligand, which led to < 20% conversion after several days, we
were pleased to find that addition of THPTA to the reaction mixture gave quantitative
conversions. In a typical reaction, the polymer, THPTA (20 equiv. to azide), and alkyne 9
(1.05 equiv. to azide) were dissolved in 95% H2O/5% DMSO such that the concentration of
alkyne 9 was 2 mM. Aqueous sodium ascorbate (1.0 M) was added followed by copper(II)
sulfate (1.0 M); two more aliquots of aqueous copper sulfate and sodium ascorbate were
added over 2 days such that their final amounts were 10 and 50 equivalents, respectively,
relative to azide. The reactions were performed at 40 °C to achieve the maximum rate
possible without inducing potential azide-olefin cycloaddition side reactions.84
Figure 4A (inset) depicts the CuAAC coupling of 9 to 100N3 as monitored by liquid-
chromatography mass-spectrometry (LC-MS). Compound 9 eluted at ~4.2 min while DOX-
loaded polymer eluted from ~3.5 – ~4 min. The unique absorbance of DOX (~500 nm)
enables facile monitoring of the CuAAC reaction; the 100N3 polymer does not absorb at 500
nm and therefore the growth of a new, broad polymer peak is attributed to CuAAC coupling
of 9 to the polymer. The time-dependent LC-MS traces (Figure 4A, inset) show an
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increasing polymer absorbance at the expense of the alkyne 9 absorbance until a final, very
high (>97%) conversion is reached. As for the case with chloride-azide exchange, one may
expect the CuAAC reaction progress to depend on DP. Figure 4A shows preparatory high-
performance liquid chromatography (prep-HPLC) 500 nm absorbance traces for several
crude nDOX polymers; the total ratio of nDOX:9 is the same for each DP which again
suggests that DP has little effect on the efficiency of reactions to these structures. The
retention times for the nDOX polymers increase slightly for each DP indicating that
polymer-column interactions are dependent on DP. The pure polymer fractions were
collected and either lyophilized to dryness or concentrated before use in subsequent
experiments. Figure 4B shows the FTIR spectrum of purified 50DOX compared to that of
50N3. The azide antisymmetric stretch at ~2100 cm−1, present in the spectrum of 50N3, is
completely absent from the 50DOX spectrum which suggests very high consumption of the
azide group. Integration of the broad aromatic resonances in the 1H NMR spectrum of
50DOX compared to the PEG methylene groups is in close agreement to that expected for
fully DOX-functionalized polymer (Figure S5). The final DOX weight percentage for the
functionalized polymers is 12.6%. As mentioned above, this value is independent of DP; it
could be adjusted by varying the PEG length or the degree of branching in the MM
precursor.
Photorelease of DOX and cell culture studies
Having successfully coupled 9 to nN3 we next studied the release of free DOX from the
brush polymer in response to UV light (~365 nm). An aqueous solution of purified nDOX
polymer was irradiated at 365 nm for a given time and subjected to LC-MS analysis. The
progress of photorelease was monitored over 10 min by repeated irradiation and LC-MS; the
data for 100DOX are shown in Figure 5A. As irradiation time increased we observed a new
peak at ~3 min that increased in intensity at the expense of the 100DOX polymer peak. The
new peak corresponds to the retention time and mass of free DOX. We also observed a
small side product at ~3.6 min with a mass of 569 Da (labelled “*” in Figure 5A), which is
likely the result of intramolecular trapping of carbamic acid 10 to give cyclic carbamate 11.
Nevertheless, the major product of UV photolysis was free DOX; the photolysis yield after
10 min irradiation was ~70% for all nDOX polymers which led us to examine the
effectiveness of these materials against human cancer cells in cell culture.
We performed cell viability experiments using MCF-7 human breast cancer cells. Cells were
treated with aqueous solutions of either free DOX or the corresponding nDOX polymer at
various concentrations and irradiated for 10 min using 365 nm light or kept in the dark. The
cells were then incubated in the dark for 24 h, washed twice, and incubated for another 24 h
in fresh, drug-free growth medium. Cell viability was assessed using the MTT assay (see
methods and materials for details). Data for n = 100 polymers (100N3 and 100DOX) are
shown in Figure 5B (cell viability data for other n values is given in the supporting
information). Free DOX, with and without UV irradiation, effectively killed the cells at 3–5
μM while azide polymer 100N3 was non-toxic with and without light up to 100 μM; these
data taken together suggest that under our conditions 10 min of 365 nm UV irradiation has
no adverse affect on cell viability nor does it interrupt the cellular toxicity of DOX. None of
the nDOX bivalent-brush polymers studied were toxic up to 50 μM in the absence of UV
irradiation; irradiation for 10 min yielded IC50 values ~7–10 μM which confirms that free
DOX generated by photorelease is therapeutically active. The IC50 values were not DP-
dependent. This observation suggests that the nDOX polymers remain in the extracellular
environment and upon photolysis free DOX is released and diffuses into the cell nucleus
where it induces apopotosis. Though in vitro experiments do not show DP-dependent
cytotoxicity, we expect that DP will affect in vivo trafficking and thus the overall utility of
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these materials in drug delivery. Targeting groups could be appended to the periphery of
these materials to promote trafficking into the cell.113
Here we have demonstrated the utility of a combined graft-through/click-to strategy for the
synthesis of a new class of clickable, branched nanostructures: PEG-branch-azide bivalent-
brush polymers. This approach makes use of the remarkable efficiency of ROMP for graft-
through polymerization and the modular coupling power of click chemistry for polymer
functionalization. A wide range of nanoscale sizes is accessible which will enable detailed
structure/function correlation in biological settings. We are currently exploring applications
for these materials in drug delivery. Design and synthesis of novel clickable linkers (e.g.
longer wavelength-, pH-, and redox-cleavable), attachment of targeting moieties at the PEG
periphery, incorporation of degradable units within the polymer backbone, and use of chain-
transfer agents to append orthogonal groups selectively to the ends of these polymers are
being studied. Furthermore, copolymerization of MMs like 6 with other monomers (such as
a norbornene-alkyl halide small molecule) will provide access to new multiblock polymer
structures with the potential for higher drug loadings.
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Figure 1.
Schematic depiction of the “graft-through and click-to” approach described in this work. A:
We start with a bivalent macromonomer (2) and perform “graft-through” ROMP with
catalyst 1 followed by in situ chloride-azide exchange. B: The resulting azido-bivalent-brush
polymer is then functionalized with an alkyne by click chemistry in a “click-to” step. If the
alkyne partner is a drug molecule linked via a cleavable linker, then the resulting brush
polymer can release the drug in response to an external stimulus. In this work we
demonstrate controlled release of the anticancer agent doxorubicin (DOX) in response to
365 nm UV light.
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Figure 2.
A: Representative GPC traces for nN3 bivalent-brush polymer samples show monomodal
molecular weight distributions, low polydispersities, and high conversions. B:
Hydrodynamic diameter histograms for selected nN3 polymers obtained from DLS
measurements using the CONTIN fitting algorithm. The particle sizes increase with
increasing DP and are varied over a wide range by adjusting the ratio of MM to catalyst
(6:1) before graft-through ROMP.
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Figure 3.
FTIR spectra of nN3 bivalent-brush polymers normalized to the strong PEG ether (C-O-C)
antisymmetric stretch absorbance. The relative amount of azide is approximately the same
for each n value which suggests that chloride-azide exchange is not sterically limited with
increased DP.
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Figure 4.
A: Prep-HPLC traces of crude CuAAC mixtures which depict similar conversion for each n
value. A (inset): Progress of CuAAC coupling of 9 to 100N3 monitored by LC-MS. B. FTIR
spectra of 50N3 and 50DOX confirming complete loss of azide after CuAAC.
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Figure 5.
A: Time-dependent UV photolysis of 100DOX monitored by LC-MS; after 10 min
irradiation ~70% of free DOX was released. A minor product (labelled “*”, see Scheme 5)
was also observed at longer irradiation times. B: Viability of MCF-7 human breast cancer
cells treated with free DOX, 100N3 bivalent-brush polymer, and drug-loaded 100DOX
polymer both with and without UV irradiation. Data points were fit to a sigmoidal function
and the half-maximum inhibitory concentrations (IC50) are shown for DOX and the
photocleaved 100DOX. The x-axis labels refer to the concentration of both free and
polymer-conjugated drug.
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Scheme 1.
Synthesis of PEG-norbornene-chloride MM 6.
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Scheme 2.
Synthesis of azido-bivalent-brush polymers (nN3) by ROMP and chloride-azide exchange.
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Scheme 3.
Synthesis of DOX-nitrobenzyloxycarbonyl (NBOC)-alkyne derivative 9 for click chemistry
and photorelease of DOX.
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Scheme 4.
CuAAC coupling of 9 to nN3 brush using tris(hydroxypropyltriazolylmethyl)amine
(THPTA) ligand, copper(II) sulfate, and sodium ascorbate as an in situ reductant.
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Scheme 5.
Photolysis of nDOX polymers gives carbamic acid 10. Decarboxylation of 10 yields free
DOX as the major product while intramolecular trapping provides DOX-carbamate
derivative 11 as a minor product (Figure 5A, labelled “*”). Reactive nitrosobenzaldehyde
photoproducts remain bound to the polymer core after photolysis.
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Table I
Characterization of nN3 bivalent brush polymers by GPC (room temp., 0.2 M LiBr in DMF, 1 mL/min) and
DLS (aqueous).
n (theo.)[a] DP[b] Mn (GPC, kDa) PDI Rh[c]/nm
10 10 34.1 1.11 3.1 (0.3)
30 32 109 1.04 6.3 (0.8)
50 53 180 1.07 6.9 (0.9)
70 70 238 1.14 7.3 (0.3)
80 80 272 1.14 7.5 (0.8)
100 101 343 1.06 11 (1)
300 295 1,000 1.11 15 (1)
400 575 1,960 1.27 25 (2)
[a]
ratio of MM to catalyst (i.e. theoretical DP). This number is used to identify nN3 and DOXN3 samples throughout the text,
[b]
DP observed derived from Mn(GPC)/Mn(MM),
[c]hydrodynamic radii measured by dynamic light scattering (DLS). DLS correlation functions were fit using the CONTIN algorithm.
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